$HNGE

Pursley James sold $479K of HNGE

Pursley James (President) sold 8,995 shares of Hinge Health, Inc. (HNGE) at $53.29 ($0.48M total) on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Pursley James
Published May 27, 2026, 11:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 11:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

This disclosure updates insider activity records but does not provide evidence of a new business development, financial result, or regulatory event. The most plausible effect is a small sentiment/positioning adjustment rather than a fundamental repricing.

02

Market read

HNGE insider selling is disclosed, but the 10b5-1 designation suggests scheduled trading with limited informational content.

03

What to watch

Traders may overreact to headline insider selling; the key nuance is the plan being pre-arranged, which often correlates with scheduled execution rather than new information.

Relevance 6/10Timing: Same-day/next-session positioning possible as traders digest the Form 4, but no new operating catalyst is present.

Background

The article is an SEC EDGAR Form 4 insider transaction: President Pursley James sold HNGE shares on 2026-05-26; the sale is marked as open-market and executed under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health (HNGE) disclosed an officer open-market sale of 8,995 shares ($479,367.84) under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited immediate impact; any reaction should be small unless accompanied by other fundamental news.

Evidence & confidence

The filing is an SEC Form 4 for an officer sale, explicitly tied to a pre-arranged 10b5-1 plan, which reduces interpretive weight versus unscheduled sales.

Market effects

Minimal—this is company-specific insider liquidity/plan activity, not a sector-wide signal.

None indicated; filing is US-based and not tied to regional demand or regulation changes.

None indicated; no international transaction or guidance change mentioned.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine diversification/liquidity rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4 insider transaction; officer sale of 8,995 shares for ~$479.4K under a 10b5-1 plan.

  • Pursley James

    President who executed the open-market sale disclosed in the Form 4.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.